Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-04
2006-07-04
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S367000, C548S169000, C548S221000
Reexamination Certificate
active
07071221
ABSTRACT:
Compounds of formula (I):wherein:X represents oxygen or sulphur or a group CH2orR1, R2, R3, R4, R5and R6are as defined in the description,A represents an alkylene chain as defined in the description,B represents alkyl or alkenyl substituted by a group or R9, or B represents a group or R9,D represents a benzene, pyridine, pyrazine, pyrimidine or pyridazine nucleus.Medicaments
REFERENCES:
patent: 6919362 (2005-07-01), Lesieur et al.
Berthelot Pascal
Boutin Jean Albert
Caignard Daniel Henri
Carato Pascal
Dacquet Catherine
Hueschen and Sage
Kosack Joseph R.
Les Laboratoires Servier
Saeed Kamal A.
LandOfFree
Heterocyclic oxime compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic oxime compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic oxime compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3562036